Teva UK Ltd
Reference: GB-COH-00302461
10
Awards
€935,959,545
Total awarded
Recent awards
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
- Project/Contract NHS National Framework for Denosumab Injection
- NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
- NHS National Framework for Transition products (Axitinib and Eltrombopag)
- NHS National Framework for Denosumab Injection commencing 1st January 2026
- Generic, Branded Generic & Proprietary Medicinal Products - Group 17
- NHS National Framework for Generics Housekeeping
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
- Generic, Branded Generic & Proprietary Medicinal Products - Group 14
- NHS National Framework for Transition products (Axitinib and Eltrombopag)
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.